Verition Fund Management’s Mural Oncology MURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-157,500
Closed -$389K 3922
2025
Q2
$389K Sell
157,500
-27,719
-15% -$65.3K ﹤0.01% 3070
2025
Q1
$233K Sell
185,219
-21,853
-11% -$79.7K ﹤0.01% 2993
2024
Q4
$667K Sell
207,072
-132,928
-39% -$469K ﹤0.01% 2299
2024
Q3
$1.06M Sell
340,000
-170,847
-33% -$556K 0.01% 1844
2024
Q2
$1.6M Sell
510,847
-281,623
-36% -$1.04M 0.01% 1395
2024
Q1
$3.88M Buy
792,470
+634,083
+400% +$3.08M 0.03% 832
2023
Q4
$938K Buy
+158,387
New +$637K 0.01% 1210

Other funds holding MURA

Verition Fund Management's MURA Position: Q3 2025 in Review

Verition Fund Management sold out of Mural Oncology (MURA) in Q3 2025, closing a stake of 157,500 shares — an estimated $389K sold.

Verition Fund Management first reported a position in MURA in Q4 2023 and held it in 7 quarters. The position peaked at $3.88M in Q1 2024. 61 funds tracked by Wall St. Rank hold MURA as of Q3 2025.

  • Verition Fund Management reported no remaining Mural Oncology position as of Q3 2025 after selling out during the quarter.
  • Verition Fund Management sold 157,500 Mural Oncology shares in Q3 2025, an estimated $389K.
  • Verition Fund Management first reported a position in Mural Oncology in Q4 2023 and held it in 7 quarters.
  • Verition Fund Management's Mural Oncology position peaked at $3.88M in Q1 2024.
  • 61 funds tracked by Wall St. Rank held Mural Oncology as of Q3 2025.

Based on Verition Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.